The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Therapeutics, Inc. | COM | 00461U105 | 31,708 | 1,258,243 | SH | SOLE | 1,258,243 | 0 | 0 | ||
| ALX Oncology Holdings Inc. | COM | 00166B105 | 23,597 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
| BCTG Acquisition Corp. | COM | 05492W103 | 4,448 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| Consonance-HFW Acquisition Corp. | UNIT | 0G244M129 | 976 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| Cullinan Oncology, Inc. | COM | 230031106 | 113,818 | 2,731,410 | SH | SOLE | 2,731,410 | 0 | 0 | ||
| FS Development Corp. II | COM CL A | 30318F100 | 6,001 | 602,500 | SH | SOLE | 602,500 | 0 | 0 | ||
| Gemini Therapeutics, Inc. | COM | 36870G105 | 32,996 | 2,435,125 | SH | SOLE | 2,435,125 | 0 | 0 | ||
| Helix Acquisition Corp. | COM CL A | G4444C102 | 2,550 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| Hims & Hers Health, Inc. | COM CL A | 433000106 | 13,983 | 1,056,922 | SH | SOLE | 1,056,922 | 0 | 0 | ||
| Immunovant, Inc. | COM | 45258J102 | 802 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| Kinnate Biopharma Inc. | COM | 49705R105 | 27,265 | 875,001 | SH | SOLE | 875,001 | 0 | 0 | ||
| LifeSci Acquisition II Corp. | COM | 53229E103 | 4,056 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| Lucira Health, Inc. | COM | 54948U105 | 5,869 | 485,000 | SH | SOLE | 485,000 | 0 | 0 | ||
| Nurix Therapeutics, Inc. | COM | 67080M103 | 14,038 | 451,522 | SH | SOLE | 451,522 | 0 | 0 | ||
| Olink Holding AB | SPONSORED ADS | 680710100 | 7,200 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| Pharvaris N.V. | COM | N69605108 | 18,583 | 664,142 | SH | SOLE | 664,142 | 0 | 0 | ||
| Population Health Investment Co., Inc. | UNIT | G71716123 | 9,648 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
| Relay Therapeutics, Inc. | COM | 75943R102 | 13,828 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| Research Alliance Corp. II | COM CL A | 760873109 | 5,125 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| Therapeutics Acquisition Corp | COM CL A | 88339T103 | 3,679 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||